4//SEC Filing
Tressler Nick B. 4
Accession 0001794362-25-000005
CIK 0001411685other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 6:07 AM ET
Size
5.9 KB
Accession
0001794362-25-000005
Insider Transaction Report
Form 4
Tressler Nick B.
Chief Financial Officer
Transactions
- Award
Common Stock (Right to Buy)
2025-12-01+150,000→ 150,000 totalExercise: $4.43Exp: 2035-12-01→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.
- [F2]The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer.
Documents
Issuer
Vistagen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001794362
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 6:07 AM ET
- Size
- 5.9 KB